http://www.techtimes.com/articles/180942/20161005/fda-warns-against-hepatitis-b-reactivation-in-some-patients-taking-direct-acting-hepatitis-c-antivirals.htm
The U.S. Food and Drug Administration has issued a warning against the potential risk of Hepatitis B virus reactivation in patients treated with direct-acting antiviral drugs for Hepatitis C virus.Patients who have already been infected by the HB virus and those who have ongoing infection are likely to develop serious liver conditions or even death when treated with HC direct-acting antiviral drugs for HC infection. The FDA has mandated the inclusion of "Boxed Warning," a prominent warning concerning the risks of HB virus reactivation on the HC direct-acting antiviral drug labels.
HAD TO CUT ARTICLE SHORT CAUSE NEW LAYOUT OF FORUM AND 84 CHARACTERS MAX SUCK